
Genvec
Get Full AccessDescription
- GenVec is an entrepreneurial clinical-stage biopharmaceutical company focused on leveraging its proprietary adenovector gene delivery platform to develop a pipeline of cutting-edge therapeutics and vaccines. The company is a pioneer in the design, testing and manufacture of adenoviral-based product candidates that can deliver on the promise of gene-based medicine. GenVec's lead product, CGF166, is licensed to Novartis and currently in a Phase 1/2 clinical study for the treatment of hearing loss and balance disorders. In addition to our internal and partnered pipeline, the company also licenses its proprietary technology platform, including vectors and production cell lines, for the development and manufacture of therapeutics and vaccines to the biopharmaceutical industry. Additional information about GenVec is available at www.genvec.com and in the company's various filings with the Securities and Exchange Commission.
-
Headquarters:910 Clopper Road Suite 220n, Gaithersburg, Maryland, United States
More -
Phone Number: +1 240-632-0740
-
Website: https://www.genvec.com
-
Employees:31
-
Revenue:$10 - 50M
-
Legal Name:Genvec
-
Genvec's Social Media
-
Is this data correct?
-
| NAICS Code: 541715 |
Show More
Frequently Asked Questions regarding Genvec
-
Where are Genvec's Headquarters?
Genvec's Headquarters are in 910 Clopper Road Suite 220n,Gaithersburg,Maryland,United States
-
What is Genvec's phone number?
Genvec's phone number is +1 240-632-0740
-
What is Genvec's official website?
Genvec's official website is https://www.genvec.com
-
What is Genvec's Revenue?
Genvec's revenue is $10 - 50M
-
What is Genvec's NAICS code?
Genvec's NAICS code is 541715
-
How many employees are working in Genvec
Genvec has 31 employees
-
What is Genvec's Industry?
Genvec is in the industry of Biotechnology
-
Who is Genvec's Senior Vice President, Prod Devel?
Genvec's Senior Vice President, Prod Devel is Mark Thornton